From October 19–23, the CORESTA Congress on Tobacco and Next-Generation Products came to an end in beautiful Annecy. The world’s leading experts gathered to discuss analytical and biological methods for risk assessment.
VITROCELL participated in the Task Force meetings on in vitro and next-generation methods, following the discussions on whole-aerosol testing at the Air-Liquid Interface. Exciting progress was shared on dosimetry and human-relevant dose assessment, and plans were made for a special workshop on market-ready Organ-on-Chip technologies.
It was a pleasure to reconnect with so many customers, collaboration partners, and friends from around the world.
